Saturn V Capital Management LP Diversified Active

CIK: 0001964437 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $264,640 (100.0% shares, 0.0% debt)

Holdings (26)

ARGX ARGENX SE 10.4%
Value ($000) $27,607 Shares 64,196 Est. Cost $394.09 Unrealized
IRON DISC MEDICINE INC 8.6%
Value ($000) $22,674 Shares 503,089 Est. Cost $47.85 Unrealized -29.0%
CRNX CRINETICS PHARMACEUTICALS IN 8.1%
Value ($000) $21,485 Shares 479,681 Est. Cost $18.62 Unrealized +148.0%
PCVX VAXCYTE INC 6.2%
Value ($000) $16,286 Shares 215,680 Est. Cost $69.08 Unrealized -1.5%
ASND ASCENDIS PHARMA A/S 5.8%
Value ($000) $15,441 Shares 113,224 Est. Cost $113.18 Unrealized
CYTK CYTOKINETICS INC 5.6%
Value ($000) $14,739 Shares 272,036 Est. Cost $40.01 Unrealized +50.9%
BMRN BIOMARIN PHARMACEUTICAL INC 5.6%
Value ($000) $14,703 Shares 178,589 Est. Cost $89.71 Unrealized -7.2%
COGT COGENT BIOSCIENCES INC 5.3%
Value ($000) $14,111 Shares 1,673,919 Est. Cost $8.70 Unrealized -12.8%
CARGO THERAPEUTICS INC 5.3%
Value ($000) $14,069 Shares 856,849 Est. Cost $16.42 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 5.0%
Value ($000) $13,293 Shares 1,128,478 Est. Cost $7.51 Unrealized +55.3%
CELC CELCUITY INC 4.7%
Value ($000) $12,464 Shares 760,941 Est. Cost $16.73 Unrealized 0.0%
MERUS N V 3.7%
Value ($000) $9,750 Shares 164,773 Est. Cost $27.10 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 3.3%
Value ($000) $8,615 Shares 419,654 Est. Cost $19.41 Unrealized +7.8%
ABVX ABIVAX SA 3.1%
Value ($000) $8,299 Shares 627,760 Est. Cost $14.30 Unrealized
IRWD IRONWOOD PHARMACEUTICALS INC 2.7%
Value ($000) $7,262 Shares 1,113,824 Est. Cost $11.37 Unrealized -37.8%
FOLD AMICUS THERAPEUTICS INC 2.7%
Value ($000) $7,078 Shares 713,536 Est. Cost $12.47 Unrealized -17.7%
ANAB ANAPTYSBIO INC 2.4%
Value ($000) $6,255 Shares 249,609 Est. Cost $18.84 Unrealized +23.6%
PHAT PHATHOM PHARMACEUTICALS INC 2.3%
Value ($000) $6,111 Shares 593,306 Est. Cost $8.81 Unrealized +16.9%
ITEOS THERAPEUTICS INC 2.1%
Value ($000) $5,453 Shares 367,429 Est. Cost $14.98 Unrealized
INOZYME PHARMA INC 1.9%
Value ($000) $5,086 Shares 1,140,310 Est. Cost $4.46 Unrealized
NMRA NEUMORA THERAPEUTICS INC. 1.4%
Value ($000) $3,835 Shares 390,084 Est. Cost $10.35 Unrealized 0.0%
ELVN ENLIVEN THERAPEUTICS INC 1.3%
Value ($000) $3,556 Shares 152,178 Est. Cost $21.05 Unrealized 0.0%
LONGBOARD PHARMACEUTICALS IN 0.7%
Value ($000) $1,931 Shares 71,442 Est. Cost $27.03 Unrealized
RAPP RAPPORT THERAPEUTICS INC 0.6%
Value ($000) $1,628 Shares 70,000 Est. Cost $23.15 Unrealized 0.0%
MORPHIC HLDG INC 0.6%
Value ($000) $1,624 Shares 47,660 Est. Cost $27.88 Unrealized
CTNM CONTINEUM THERAPEUTICS INC 0.5%
Value ($000) $1,283 Shares 72,831 Est. Cost $16.10 Unrealized 0.0%